Managing Antithrombotic Therapies in Patients With Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention


This brief CME publication reviews the current evidence on antithrombotic therapy for patients with atrial fibrillation (AF) who have undergone percutaneous coronary intervention (PCI) and explores the emerging standards of care in this setting. In addition, this activity features a short video that provides expert commentary from Renato Lopes, MD, on the challenge of managing antithrombotic therapy for these patients and how the evidence from recent clinical trials is informing practice.

Online Publication
0.25 AMA PRA Category 1 Credit™

Renato D. Lopes, MD, MHS, PhD
Professor of Medicine, Division of Cardiology
Duke Clinical Research Institute